These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7426194

  • 1. Primary pulmonary hypertension: effects of nifedipine.
    Camerini F, Alberti E, Klugmann S, Salvi A.
    Br Heart J; 1980 Sep; 44(3):352-6. PubMed ID: 7426194
    [Abstract] [Full Text] [Related]

  • 2. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
    Khosseĭn A, Mareev VIu, Ageev FT, Sazonova LN, Lobova NM.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988 Sep; 11(1):78-81. PubMed ID: 3401345
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S, Salvi A, Fioretti P, Camerini F.
    G Ital Cardiol; 1982 Sep; 12(7):505-8. PubMed ID: 7169146
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rapid attenuation of response to nifedipine in primary pulmonary hypertension.
    Wood BA, Tortoledo F, Luck JC, Fennell WH.
    Chest; 1982 Dec; 82(6):793-4. PubMed ID: 7140411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA, Pressly TA, Mukerji V, Lambert CR, Mukerji B, Panayiotou H, Sharp GC.
    Am J Cardiol; 1991 Dec 15; 68(17):1687-91. PubMed ID: 1746473
    [Abstract] [Full Text] [Related]

  • 9. [Primary pulmonary arterial hypertension. Trial treatment with nifedipine, diazoxide and isoproterenol].
    Thomas D, Drobinski G, Komajda M, Grosgogeat Y.
    Nouv Presse Med; 1980 Dec 20; 9(48):3698-9. PubMed ID: 7454591
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N, el Allaf D, D'Orio V, Cremers S, Marcelle R, Carlier J.
    Acta Cardiol; 1985 Dec 20; 40(2):207-15. PubMed ID: 3873156
    [Abstract] [Full Text] [Related]

  • 11. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G.
    Schweiz Med Wochenschr; 1985 Sep 28; 115(39):1345-7. PubMed ID: 4071009
    [Abstract] [Full Text] [Related]

  • 12. Diazoxide in treatment of primary pulmonary hypertension.
    Wang SW, Pohl JE, Rowlands DJ, Wade EG.
    Br Heart J; 1978 May 28; 40(5):572-4. PubMed ID: 656227
    [Abstract] [Full Text] [Related]

  • 13. Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months.
    Musante R, Di Donato M.
    G Ital Cardiol; 1985 Nov 28; 15(11):1110-2. PubMed ID: 3830769
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR, Beekman RH, Rosenthal A.
    Pediatr Res; 1988 Aug 28; 24(2):186-90. PubMed ID: 3186330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thromboxane synthetase inhibition in primary pulmonary hypertension.
    Rich S, Hart K, Kieras K, Brundage BH.
    Chest; 1987 Mar 28; 91(3):356-60. PubMed ID: 3545698
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M.
    Schweiz Med Wochenschr; 1994 Oct 01; 124(39):1701-7. PubMed ID: 7939536
    [Abstract] [Full Text] [Related]

  • 18. [Use of nifedipine in primary arterial pulmonary hypertension].
    Levigard RM, Assad JE.
    Arq Bras Cardiol; 1982 Jul 01; 39(1):67-9. PubMed ID: 7168690
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haemodynamic effects of a calcium antagonistic agent (nifedipine) in hypertension: therapeutic implications.
    Bartorelli C, Magrini F, Moruzzi P, Olivari MT, Polese A, Fiorentini C, Guazzi M.
    Clin Sci Mol Med Suppl; 1978 Dec 01; 4():291s-292s. PubMed ID: 282070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.